Online Program

339531
Intersection of drug use and transportation


Monday, November 2, 2015 : 10:30 a.m. - 10:50 a.m.

Bella Dinh-Zarr, PhD, MPH, National Transportation Safety Board, Washington, DC

Cases of substance impairment are increasing in all modes of transportation. In the United States, more than 10,000 people died in alcohol-impaired driving crashes, and 9.9 million reported driving under the influence of illicit drugs (NHTSA 2014; SAMHSA 2013). The NTSB recently studied trends in toxicology findings from fatally-injured airplane pilots and found their use of potentially impairing substances, including prescription and over-the-counter medications, has been increasing. In fact, the most common drug identified in these pilots was diphenhydramine, a sedating antihistamine available in a variety of allergy, cold, and sleep medications. With alcohol continuing to be a factor in nearly one-third of all motor vehicle fatalities and with prescription and over-the-counter drug sales increasing over the past decade, including controlled substances and other sedating medications, substance impairment has become a real concern for all transportation operators. We have seen how these substances impair the ability to fly, drive, and sail safely. I will be discussing why these issues are posing a public health problem.

Learning Areas:

Clinical medicine applied in public health
Occupational health and safety
Public health or related organizational policy, standards, or other guidelines
Public health or related public policy
Social and behavioral sciences

Learning Objectives:
Describe why drugs, alcohol and issues affecting the safe operation of a plane, motor vehicle, boat or train are public health issues. Identify ways to reduce the risk associated with substance use by operators across the transportation modes.

Keyword(s): Drug Abuse, Transportation

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the 42nd Board Member of the National Transportation Safety Board. I am trained as a public health scientist, specializing in injury prevention, and have dedicated my career to working to ensure that transportation safety is a policy priority—both domestically and internationally. I previously served as the U.S. Director and Road Safety Director of the FIA Foundation, an international philanthropy with the mission of promoting safe and sustainable surface transportation
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.